DEA Allows Bulk Psilocybin Production for Medical Studies
Published Date: 2/13/2026
Notice
Summary
Scottsdale Research Institute wants to make large amounts of psilocybin and psilocyn, two powerful research drugs, to help with their studies and clinical trials. People and companies involved with these drugs can share their thoughts or ask for a hearing by April 14, 2026. This move could speed up important medical research while keeping safety rules in check.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
Application to Bulk‑Manufacture Psilocybin
On January 8, 2026, Scottsdale Research Institute (12815 North Cave Creek Road, Phoenix, AZ 85022) applied to be registered as a bulk manufacturer of psilocybin (code 7437) and psilocyn (code 7438), both listed as Schedule I. The application says the company plans to bulk manufacture those substances only for internal research purposes and to support clinical trials, and that no other activities for those drug codes would be authorized.
Comment and Hearing Deadline: April 14, 2026
Registered bulk manufacturers of the affected basic classes, and applicants, may submit electronic comments or objections or file a written request for a hearing on the Scottsdale Research Institute application on or before April 14, 2026. Comments must be submitted through https://www.regulations.gov and submitters will receive a Comment Tracking Number when their comment is successfully filed.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in